Head and Neck Squamous Cell Carcinoma Market - Top Companies and Manufacturers

Companies Dominating the Head and Neck Squamous Cell Carcinoma (HNSCC) Landscape

Immutep Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Novartis AG
Fortress Biotech, Inc.
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bristol Myers Squibb Company
AstraZeneca PLC
Pfizer Inc.
Boehringer Ingelheim International GmbH
Checkpoint Therapeutics, Inc.

Browse Key Market Insights with Data Illustration:

Head and Neck Squamous Cell Carcinoma (HNSCC) Market Size & Share, Growth Trends 2036

In the News

Immutep Limited announced that it has completed the recruitment of patients having head and neck cancer and has safely dosed them for stage 2 of Part C of its Two ACTive Immunotherapies (TACTI-002) Phase II study trials.
Checkpoint Therapeutics, Inc. announced that it has expanded its partnership with Samsung Biologics Co., Ltd. for manufacturing the anti-PD-L1 antibody, cosibelimab on a commercial scale.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of head and neck squamous cell carcinoma is assessed at USD 2.35 Billion.

The head and neck squamous cell carcinoma market size was over USD 2.18 Billion in 2023 and is anticipated to reach USD 6.51 Billion by the end of 2036, growing at around 8.8% CAGR during the forecast period i.e., between 2024-2036. Growing R&D and approvals for cancer drugs and treatment, escalating consumption of alcohol, and growing adoption of immune therapeutics are the major factors driving the market growth.

North America is poised to dominate majority industry share of about 52% by 2036, propelled by increasing frequency of head and neck cancer driven by surging ratio of alcohol, and tobacco consumption in people in the region.

Immutep Limited, Novartis AG, Fortress Biotech, Inc., F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Bristol Myers Squibb Company, AstraZeneca PLC, Pfizer Inc., Boehringer Ingelheim International GmbH, Checkpoint Therapeutics, Inc.

Head and Neck Squamous Cell Carcinoma Market - Top Companies and Manufacturers

Companies Dominating the Head and Neck Squamous Cell Carcinoma (HNSCC) Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the head and neck squamous cell carcinoma market market worth?

Why is the demand for head and neck squamous cell carcinoma market growing?

Which region dominated the majority of head and neck squamous cell carcinoma market industry share?

Who are the top head and neck squamous cell carcinoma market companies?